<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03354494</url>
  </required_header>
  <id_info>
    <org_study_id>SMD-DSG-2017-15</org_study_id>
    <nct_id>NCT03354494</nct_id>
  </id_info>
  <brief_title>Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa for Ovarian Stimulation in Donors</brief_title>
  <official_title>Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa for Ovarian Stimulation in Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Universitari Dexeus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Universitari Dexeus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, controlled ovarian stimulation (COS) in oocyte donors is performed by daily
      injections of gonadotropins( recombinant FSH) plus a GnRH Antagonist usually form 5th-6th
      stimulation day until ovulation induction with a bolus of another injection of a
      gonadotropin-releasing hormone (GnRH) Agonist. Injections of the GnRH Antagonist avoid
      untimely luteinizing hormone (LH) surge and spontaneous ovulation prior to follicular
      aspiration. There is a preparation of long-acting recombinant follicle stimulating hormone
      (rFSH= (corifollitropin alfa (FSH-CTP), Elonva®, MSD), that allows that a single subcutaneous
      injection substitutes the first 7 days of daily gonadotropin injections. On the other hand, a
      contraceptive oral progesterone only( Desogestrel, DSG) is available for contraception,
      avoiding the LH surge.

      In donors, by administering a single injection of FSH-CTP and oral desogestrel since the
      first menstruation day, the total number of injections administered is reduced and less
      discomfort is experienced without adverse impact on ovarian response.

      Other authors have reported good results using similar synthetic progestins
      (Medroxyprogesterone, dihydrogesterone, and natural progesterone).

      No description of the hormonal and ovarian response under this protocol has been published.
      Direct comparison between this novel protocol and the classical GnRH- antagonist plus daily
      gonadotropins has not been reported.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total dose of gonadotrophins</measure>
    <time_frame>At the end of stimulation treatment period (from day of corifollitropin administration until the day of triggering) ) an average 10 days after beginning treatment</time_frame>
    <description>Sum of gonadotrophins dose</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oocyte retrieved</measure>
    <time_frame>Oocyte retrieval day an average 10 days after beginning treatment</time_frame>
    <description>Number of oocyte retrieved</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Controlled Ovaria Stimulation</condition>
  <arm_group>
    <arm_group_label>DSG-CTP</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desogestrel (DSG) and Corifolitropin (FSH-CTP) Alfa</intervention_name>
    <arm_group_label>DSG-CTP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - Population: donors (18-35 ) from candidates of Donor program
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Fulfilling inclusión medical and legal criteria (RD - Spanish law adapting european
        rule-9/2014)

          -  Who had had undergone previously convencional COS (controlled ovarian stimulation)
             with FSH-CTP and daily antagonist injections

          -  Given signed consent form.

        Exclusion Criteria:

          -  Previous low response to COS

          -  Previous ovarian hyperstimulation syndrome.

          -  Ovarian cysts.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <link>
    <url>http://www.dexeus.com</url>
  </link>
  <reference>
    <citation>Martínez F, Boada M, Coroleu B, Clua E, Parera N, Rodríguez I, Barri PN. A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH. Hum Reprod. 2006 Aug;21(8):2121-5. Epub 2006 Apr 21.</citation>
    <PMID>16632462</PMID>
  </reference>
  <reference>
    <citation>Martínez F, Clua E, Santmartí P, Boada M, Rodriguez I, Coroleu B. Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors. Fertil Steril. 2010 Nov;94(6):2433-6. doi: 10.1016/j.fertnstert.2010.02.059. Epub 2010 Apr 28.</citation>
    <PMID>20430379</PMID>
  </reference>
  <reference>
    <citation>Requena A, Cruz M, Collado D, Izquierdo A, Ballesteros A, Muñoz M, García-Velasco JA. Evaluation of the degree of satisfaction in oocyte donors using sustained-release FSH corifollitropin α. Reprod Biomed Online. 2013 Mar;26(3):253-9. doi: 10.1016/j.rbmo.2012.11.015. Epub 2012 Dec 5.</citation>
    <PMID>23352098</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2017</study_first_submitted>
  <study_first_submitted_qc>November 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 28, 2017</study_first_posted>
  <last_update_submitted>November 24, 2017</last_update_submitted>
  <last_update_submitted_qc>November 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Universitari Dexeus</investigator_affiliation>
    <investigator_full_name>Dr. Francisca Martínez</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>Oocyte donors</keyword>
  <keyword>Ovarian stimulation</keyword>
  <keyword>Desogestrel</keyword>
  <keyword>Corifolitropina alfa</keyword>
  <keyword>Gonadotropins</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Desogestrel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

